Model
Edge
Alnylam Pharmaceuticals, Inc.
0001708764
Filing Type
4
Filing Date
2/4/2024
Updated
2/5/24, 9:05 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership